SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharmaceuticals reports 24% rise in Q2 consolidated net profit

25 Oct 2023 Evaluate

Torrent Pharmaceuticals has reported results for second quarter ended September 30, 2023 (Q2FY24). 

The company has reported 20.22% rise in its net profit at Rs 327 crore for Q2FY24 as compared to Rs 272 crore for the same quarter in the previous year. Total income of the company increased by 11.45% at Rs 2,161 crore for Q2FY24 as compared Rs 1,939 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 23.72% rise in its net profit at Rs 386 crore for the quarter under review as compared to Rs 312 crore for the same quarter in the previous year. Total income of the company increased by 16.43% at Rs 2,686 crore for Q2FY24 as compared Rs 2,307 crore for the corresponding quarter previous year.


Torrent Pharma Share Price

4178.85 22.50 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×